MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines . MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular, Renal & Metabolic Diseases, and Infection and Vaccines.
Johnson & Johnson Innovation
Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical devices and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, JLABS, Johnson & Johnson Innovation – JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs for patients. For more information please visit: www.jnjinnovation.com.
Pfizer colleagues take pride and satisfaction in contributing to one of the greatest human endeavors – innovating to bring therapies to patients that significantly improve their lives. At Kendall Square, one of Pfizer’s largest worldwide research and development hubs, scientists are working to discover and develop transformative medicines for a spectrum of needs, including rare diseases, atopic dermatitis, rheumatoid arthritis, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), inflammatory bowel disease, muscular dystrophy, and alopecia. Colleagues thrive in an environment of shared trust, diversity of experience, and a passion for excellence. We are proud to be part of a global community within Pfizer and beyond, collaborating with the best minds in the field to explore what’s possible and extend our positive impact to people around the world.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
Bill & Melinda Gates Medical Research Institute
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Based in Cambridge, our mission is to develop products to fight malaria, tuberculosis, diarrheal diseases and serious maternal and child health disorders — major causes of mortality, poverty, and inequality in low- and middle-income countries. With unprecedented scientific tools at our disposal, now is the time to use them to save the lives of the world’s poorest people. Our focus is translational medicine: advancing novel drug and vaccine candidates from the laboratory to human studies. Funneling many possible ideas into a few viable solutions is the most challenging stage of the research and development process, and we embrace this challenge.